Nine medicinal plants and their stick-type medicinal concentrated beverages (SMCB-I and SMCB-II) with different combination ratio were evaluated on antioxidant, nitric oxide (NO) inhibitory, and antibacterial effects against pathogenic bacteria involved in respiratory system illnesses. Antioxidant activity was high in Syzygium aromaticum, Pueraria lobata, Plantago asiatica, and Kalopanax pictus which have higher contents of total phenolics and total flavonoids. The NO inhibitory activity was high in Syzygium aromaticum, Plantago asiatica, and Glycyrrhiza uralensis. Syzygium aromaticum, Plantago asiatica, Kalopanax pictus and Glycyrrhiza uralensis showed higher antibacterial activity than the other five medicinal plants against Staphylococcus aureus, Corynebacterium diphtheriae, and Mycobacterium sp. SMCB-II exhibited higher antioxidant, NO inhibitory, and antibacterial effects than SMCB-I, since Syzygium aromaticum, Pueraria lobata, and Kalopanax pictus were only used for the production of SMCB-II. The SMCBs would be expected to contribute to an easy-to-carry, easy-to-consume, and high value-added health beverage for the modern people.

评估了九种药用植物及其不同配比的棒状药用浓缩饮料（SMCB-I 和 SMCB-II）对呼吸系统疾病相关病原菌的抗氧化、一氧化氮 (NO) 抑制和抗菌作用。总酚类和总黄酮含量较高的丁香、葛根、车前草和鹿角木具有较高的抗氧化活性。NO抑制活性在丁香、车前草和甘草中较高。香蒲、车前草、Kalopanax pictus和Glycyrrhiza uralensis对金黄色葡萄球菌、白喉棒状杆菌和分枝杆菌的抗菌活性高于其他五种药用植物。SMCB-II表现出较高的抗氧化作用，抑制NO，和比SMCB-I的抗菌效果，因为丁香，葛根，和剌楸只用于生产SMCB-II的。SMCB 有望为现代人提供易于携带、易于消费和高附加值的健康饮料。